Lowest Price Guaranteed
Slides
234
Last Updated
February 2026
View Count
15728
The global synthetic biology market is projected to grow from USD 23.88 billion in 2025 to USD 130.67 billion by 2035, representing a compounded annual growth rate of 18.53% during the forecast period.
 |
To learn more about this report, request a free sample copy
Synthetic biology refers to biological systems that are specifically engineered using different molecular technologies and tools to develop medicine and other bio-based products. The demand for synthetic biology is experiencing significant growth driven by the growing uptake of targeted therapies, biologics and biology-based products. Synthetic biology enables the development of custom-designed organisms, empowering pharmaceutical industries for designing vaccines, semi-synthetic drugs and understanding disease mechanisms. In addition to pharmaceuticals, the demand for synthetic biology has significantly increased in biotechnology industry, agriculture and environmental field. Additionally, the growing shift towards biofuel or green fuel and sustainable / biodegradable products has further driven the market growth. Driven by the increasing usage across different industrial verticals, synthetic biology technologies are increasingly maturing, making a substantial way to manufacture sustainable bio-based solutions.
Furthermore, synthetic biology frontiers are expanding their usage as a tool for DNA read, write and edit of the organisms to make valuable products. It is important to note here that Genomatica has achieved success in the development of microorganism-based production process (Geno proprietary technology) that converts renewable carbon of sugar plants into precursor to nylon (100% renewable carbon-based nylon-6). Furthermore, top fashion brands, such as Modern Meadow, Bolt Threads and VitroLabs utilize advanced technologies to develop sustainable materials using synthetic biology. The adoption of synthetic biology has significantly increased in the agriculture sector for research and development purposes. For instance, in January 2024, Rice University launched the Rice Synthetic Biology Institute to initiate collaborative research in synthetic biology and convert it into beneficial technologies.
In addition to the growing usage of synthetic biology across different domains, the high demand for early disease diagnosis and treatment is encouraging research and development in advanced genetic technologies. It is interesting to note here that the growing research on the development of cancer treatment has encouraged the adoption of synthetic biology. This synthetic biology technology is used to develop enabling products such as glutaminase, arginase, oxidase, dehydrogenase, deiminase and ribonuclease that act as core products in evaluating cancer causing cells and development of therapies. Considering these trends, we believe that synthetic biology market will continue to grow at a substantial rate during the forecast period.
The market research report presents an in-depth analysis of various industrial players that are involved in global synthetic biology industry, across different segments, as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Market Size 2035 | USD 130.67 billion | |
| Market CAGR | ~18.53% | |
| Type of Product |
|
|
| Type of Tool |
|
|
| Type of Technology |
|
|
| Type of Application |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the synthetic biology market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
Additionally, the market report features the likely distribution of market based on the type of product (core products, enabling products and enabled products), type of tool (oligonucleotides and synthetic DNA, enzymes, cloning technology kits, and synthetic cells), type of technology (gene synthesis, genome engineering, microfluidics, nanotechnology, sequencing, bioinformatics, site-directed mutagenesis, cloning, measurement and modeling, and polymerase chain reaction), type of application (healthcare, artificial tissue & tissue regeneration, industrial, environmental, food and agriculture), end user (biotechnology and pharmaceutical companies, academic and research institutes and other end users), geographical region (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
To account for the uncertainties associated with the development of synthetic biology technologies and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
Based on the type of product, the global synthetic biology market is segmented into core products, enabling products and enabled products. Currently, core products account for the highest share of the market. This can be attributed to the fact that core products are primarily used for the development of a wide range of synthesis products such as synthetic DNA, synthetic genes, and synthetic cells. However, it is important to highlight here that enabled products will grow at a higher CAGR during the forecast period. This can be attributed to the high demand for enabled products, such as gene therapy, biologics, and synthetic vaccines specifically, that are obtained as a final product of synthetic biology.
The global market is categorized based on the type of tool into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, and synthetic cells. According to our projection, oligonucleotides and synthetic DNA holds the highest synthetic biology market share (around 36%). The highest share is due to the fact that oligonucleotides serve as a building block in synthetic biology.
These oligonucleotides help in the development of synthetic genomes, genetic engineering and modified genes, which is likely to propel the growth of this segment during the forecast period. However, in the long run, enzymes is expected to grow at a higher CAGR during the forecast period. This lucrative growth is due to the broader application of enzymes including DNA manipulation, protein engineering, and biochemical processes.
Based on the type of technology, the global synthetic biology market is segmented into gene synthesis, genome engineering, microfluidics, nanotechnology, sequencing, bioinformatics, site-directed mutagenesis, cloning, measurement and modeling, and polymerase chain reaction. According to our projection, gene synthesis holds the highest share of the market. Gene synthesis has been widely adopted for the development of customized genes therapies. Furthermore, gene synthesis ensures accurate construction of customized genes or DNA sequences that aid in therapeutic development, diagnosis tools development and research purposes.
However, it is important to highlight here that genome engineering is anticipated to grow at a substantial CAGR during the forecast period. Genome engineering / genome editing has been widely adopted across different applications such as medicine and agriculture industry. Notably, genome engineering enables the development of genetically modified crops and enhances the nutritional content.
This segment highlights the distribution of global market across various types of applications, such as healthcare, artificial tissue & tissue regeneration, industrial, environmental, food and agriculture. Among these applications, presently healthcare accounts for the highest synthetic biology market share. Healthcare industry play a significant role in disease diagnosis and development of therapeutic drugs. Furthermore, the adoption of personalized medicines, biologics and target specific biopharmaceuticals by the healthcare industry to enhance treatment outcomes has further fueled the demand for synthetic biology.
However, non-healthcare segments such as agriculture and environmental will show lucrative growth and is projected to grow at a higher CAGR during the forecast period. This can be attributed to growing innovation in synthetic biology technologies that aid in the development of sustainable bioplastics, biofuels and crop improvement solutions. Additionally, the growing demand for environmentally friendly products to reduce environment impact is expected to drive this segment during the forecast period.
Based on the end user, the global synthetic biology market is distributed into biotechnology and pharmaceutical companies, academic and research institutes and other end users. According to our projection, currently biotechnology and pharmaceutical companies segment holds the highest share (around 55%) of the market. This can be attributed to the fact that biotechnology and pharmaceutical companies play a significant role in the development of advanced therapies, such as monoclonal antibodies, gene therapies and personalized medicine. Moreover, growing demand for effective vaccines and DNA-based drugs has further solidified the growth of this segment.
However, academic research and institutes will grow at a lucrative CAGR during the forecast period. This highest growth potential is primarily due to the fact that academic research and institutes remain at the forefront for technological innovations and development of advanced bio-based products using synthetic biology.
The global synthetic biology market size is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, North America dominates the market with a share of ~40% during the forecast period. This dominance is attributed to the increasing technological advancements and rising investment from public, private sectors, venture capital and government initiatives. Moreover, growing research on advanced targeted therapies and high demand for sustainable bio-based solutions in healthcare and agriculture industry is encouraging synthetic biology applications in this field.
However, in the long run, Asia-Pacific will grow at a higher CAGR during the forecast period. This can be attributed to the high economic growth, growing industrialization and increasing usage for synthetic biology for the development of advanced therapeutics. Furthermore, Asian countries like China, India, Japan and Korea are experiencing rapid industrialization has surge the demand for synthetic biology across various industrial verticals.
The “Synthetic Biology Market: Industry Trends and Global Forecast, till 2035” market report features a detailed study of the current market landscape, market size, market forecast and future opportunities for the developers of synthetic biology. Further, the market research report underlines an in-depth analysis, highlighting the capabilities of stakeholders engaged in the market.
The market landscape seems highly competitive, featuring the presence of several well-established and new entrants. Presently, the key players of the industry are focusing on the development of synthetic biology-based products for different industrial use. In order to leverage the competitive edge, several industrial leaders are raising capital investments for product portfolio expansion and developing custom synthetic biology technology that can be used across various industrial verticals. However, the primary focus will be on utilizing advance technologies to design synthetic gene circuits to identify broad range of disease indicators with a single test, leads to accurate diagnosis. As more industrial players encourage research on synthetic biology, this market will remain competitive, witnessing unprecedented growth during the forecast period.
Synthetic biology market is experiencing an upward trajectory driven by the growing technological advancements and rising demand for personalized medicines. Advanced technologies such as gene editing tools, genetic engineering and CRISPR-Cas9 enable the modification of microorganisms genes with higher precision. With custom engineered genes researchers can develop personalized gene therapies to treat a broad range of diseases including cancer, sickle cell anemia and cystic fibrosis. Moreover, the growing shift towards biomanufacturing to develop a wide variety of products for different industrial verticals has accelerated the synthetic biologics market growth.
The market for synthetic biology is experiencing several challenges that hinder its adoption on a large scale. Some of the potential challenges include high initial cost and lack of standardization. Notably, the development of synthetic biology technologies and solutions required advanced engineering solutions that significantly increase the overall expenditure. Moreover, the technological complexities associated with the designing, engineering and integration of these technologies with existing manufacturing units may impact efficiency and reliability, thereby impacting its adoption rate. It is important to highlight here that absence of standardized technologies and protocols for the development of synthetic biology may create potential challenges for industrial players.
The market for synthetic biology is witnessing an upward trajectory and is expected to grow at a steady rate, driven by the ongoing trends. Currently, the key trends include integration of artificial intelligence for the evaluation of biological phenomena and designing specific objectives within synthetic biology. Additionally, the integration of machine learning technology in biological domain for accurate analysis and decision making in synthetic biology field is contributing to the growth of this market. In October 2024, Absci entered into a strategic partnership with Twist Bioscience, in order to use former’s AI de novo design capabilities and latter’s silicon-based synthesis platform, for the designing of novel therapeutic antibody (using generative AI). As stated by Sean McClain (Chief Executive Officer, Absci), “Bringing together two leaders in biotechnology innovation represents an opportunity to accelerate pharmaceutical R&D. We are excited to strengthen our relationship with Twist and leverage the power of our shared platforms to bring better biologics to patients faster.”
Moreover, the growing shift towards sustainable biodegradable products to reduce waste generation and encourage green fuel are the key trends of this industry that encourage industrial players to make considerable initiatives in this field.
North America accounts for the highest share of the market. This dominance is due to strong research infrastructure and the presence of research institutes that are driving innovations in the synthetic biology industry. The growing demand for sustainable biology-based products in the healthcare and agriculture sector encourages researchers to develop wider synthetic biology applications.
In addition to North America, Europe also holds a significant share driven by the growing public funding and support from the European Union for research on synthetic biology. It is important to highlight here that in November 2024, UK Research and Innovation invested GBP 5.8 million to seed corn and proof of concept initiatives. These funds will be used for engineering biology or synthetic biology that are further used for the development of vaccines, plastic-free packaging and bio-based fuels for transportational. Additionally, the strong environmental regulations and demand for eco-friendly solutions is driving industrial growth in this region.
Currently, the synthetic biology market is valued at USD 23.88 billion and is poised to reach USD 130.67 billion by 2035. With growing interest of industrial players in synthetic biology for the development of green chemicals, biodegradable materials and biofuels, this market is continually expanding at a steady rate. In order to fulfill the demand, several industrial players have taken strategic initiatives including collaborations and partnerships. For instance, in June 2024, Bota Biosciences announced the commercialization of its biomanufacturing technology, through inking a deal with Zhejiang NHU. Owing to the growing preferences for translating the capabilities to commercialization scale and bringing strategic initiatives, this market will continue to grow at a CAGR of 18.53% during the forecast period.
Examples of leading players engaged in this domain (which have also been captured in this report) include BASF, Codexis, Eurofins Scientific, GenScript, Illumina, Merck, Precigen, Thermo Fisher Scientific, Agilent Technologies, Bota Bio, Creative Biogene, Elevate Bio, Gingko Bioworks, New England Biolabs, Synbio Technologies, Synthego, Creative Enzymes, Novozymes, Pareto Bio, Scarab Genomics. This synthetic biology market report includes an easily searchable excel database of all the companies focusing on synthetic biology solutions.
Several recent developments have taken place in the field of synthetic biology. We have outlined some of these recent initiatives below.